{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:00:42Z","timestamp":1792706442354,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL118277"],"award-info":[{"award-number":["HL118277"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["NO1-HC-35130"],"award-info":[{"award-number":["NO1-HC-35130"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jchf.2020.09.006","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T20:50:07Z","timestamp":1605127807000},"page":"100-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Worsening Kidney Function Is the Major\u00a0Mechanism of Heart\u00a0Failure in Hypertension"],"prefix":"10.1016","volume":"9","author":[{"given":"Maedeh","family":"Khayyat-Kholghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Oparil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa G.","family":"Tereshchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2020.09.006_bib1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jchf.2020.09.006_bib2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2020.09.006_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","article-title":"Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease","volume":"45","author":"Wali","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.006_bib4","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1681\/ASN.2008060621","article-title":"Hypertension-associated kidney disease: perhaps no more","volume":"19","author":"Freedman","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2020.09.006_bib5","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/eurheartj\/ehr242","article-title":"Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney","volume":"32","author":"Ruggenenti","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2020.09.006_bib6","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/eurheartj\/ehr238","article-title":"Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial","volume":"32","author":"Blair","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2020.09.006_bib7","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/eurheartj\/ehs205","article-title":"The role of the kidney in heart failure","volume":"33","author":"Metra","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2020.09.006_bib8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0895-7061(96)00037-4","article-title":"Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"9","author":"Davis","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jchf.2020.09.006_bib9","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2020.09.006_bib10","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2020.09.006_bib11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMsa1603542","article-title":"Use of the National Heart, Lung, and Blood Institute Data Repository","volume":"376","author":"Coady","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2020.09.006_bib12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archinte.164.9.969","article-title":"The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","volume":"164","author":"Rahman","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jchf.2020.09.006_bib13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1053\/ajkd.2002.32765","article-title":"Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate","volume":"39","author":"Coresh","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2020.09.006_bib14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.165.8.936","article-title":"Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"165","author":"Rahman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jchf.2020.09.006_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ahj.2006.10.012","article-title":"The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure validation study: diagnosis and prognosis","volume":"153","author":"Einhorn","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2020.09.006_bib16","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/CIRCULATIONAHA.107.762229","article-title":"Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"118","author":"Davis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2020.09.006_bib17","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1161\/CIRCULATIONAHA.105.544031","article-title":"Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","volume":"113","author":"Davis","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2020.09.006_bib18","article-title":"Prevention of heart failure in hypertension-disentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: the ALLHAT study","volume":"8","author":"Johnson","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2020.09.006_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00001648-199203000-00013","article-title":"Identifiability and exchangeability for direct and indirect effects","volume":"3","author":"Robins","year":"1992","journal-title":"Epidemiology"},{"key":"10.1016\/j.jchf.2020.09.006_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/a0031034","article-title":"Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros","volume":"18","author":"Valeri","year":"2013","journal-title":"Psychol Methods"},{"key":"10.1016\/j.jchf.2020.09.006_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1161\/CIRCULATIONAHA.110.012575","article-title":"Long-term follow-up of participants with heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"124","author":"Piller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2020.09.006_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7326\/0003-4819-144-3-200602070-00005","article-title":"Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate","volume":"144","author":"Rahman","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jchf.2020.09.006_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative","volume":"31","author":"Ronco","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2020.09.006_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2215\/CJN.00730805","article-title":"Kidney-heart interactions: epidemiology, pathogenesis, and treatment","volume":"1","author":"Berl","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2020.09.006_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11906-019-0993-0","article-title":"Is heart failure with preserved ejection fraction a kidney disorder?","volume":"21","author":"Shah","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jchf.2020.09.006_bib26","first-page":"911","article-title":"Hypertension, obesity, diabetes, and heart failure-free survival: the Cardiovascular Disease Lifetime Risk Pooling Project","volume":"4","author":"Ahmad","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2020.09.006_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11","author":"Borlaug","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2020.09.006_bib28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archinte.165.8.923","article-title":"Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease","volume":"165","author":"Hsu","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jchf.2020.09.006_bib29","first-page":"586","article-title":"Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction","volume":"2","author":"Katz","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2020.09.006_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2020.09.006_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11906-005-0044-x","article-title":"Does ALLHAT change the management of hypertension in chronic kidney disease?","volume":"7","author":"MacKinnon","year":"2005","journal-title":"Curr Hypertens Rep"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177920305540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177920305540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:46:33Z","timestamp":1778852793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177920305540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213177920305540"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2020.09.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.15.20132241","asserted-by":"object"}]},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Worsening Kidney Function Is the Major\u00a0Mechanism of Heart\u00a0Failure in Hypertension","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2020.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}